Zacks Investment Research upgraded shares of Ventas (NYSE:VTR) from a sell rating to a hold rating in a research note published on Wednesday, November 22nd.
According to Zacks, “Ventas has a diversified portfolio and rising healthcare spending as well as aging population offer scope for long-term growth. Further, the sale of skilled nursing facilities (SNFs) is likely to render stability as this asset class is becoming susceptible to top-line pressure amid the change in medical billing procedure. Also, Ventas is making decent investments in university-based life science real estates. Such investments offer scope to capitalize on growing health-care-driven research and development, supported by top-tier research universities. Yet, rising supply of senior housing assets is likely to moderate rent and occupancy growth. Further, near-term dilutive impact on earnings from property dispositions cannot be bypassed. Also, shares of Ventas underperformed the industry it belongs to, year to date.”
Several other research analysts also recently weighed in on VTR. BidaskClub downgraded shares of Ventas from a sell rating to a strong sell rating in a research note on Wednesday, August 9th. UBS decreased their target price on shares of Ventas from $69.00 to $66.00 and set a neutral rating for the company in a research note on Monday, October 2nd. SunTrust Banks set a $67.00 target price on shares of Ventas and gave the company a hold rating in a research note on Sunday, October 29th. BMO Capital Markets reiterated a sell rating and set a $62.00 price objective on shares of Ventas in a research note on Wednesday, October 18th. Finally, Royal Bank Of Canada reiterated a buy rating on shares of Ventas in a research note on Wednesday, September 6th. Eight analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of Hold and an average target price of $64.44.
Shares of Ventas (NYSE:VTR) opened at $63.53 on Wednesday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.46 and a current ratio of 1.46. Ventas has a 52 week low of $58.96 and a 52 week high of $72.36. The stock has a market cap of $22,430.00, a P/E ratio of 15.04, a price-to-earnings-growth ratio of 4.04 and a beta of 0.09.
Ventas (NYSE:VTR) last announced its earnings results on Friday, October 27th. The real estate investment trust reported $0.44 earnings per share for the quarter, missing the consensus estimate of $1.04 by ($0.60). The firm had revenue of $899.90 million during the quarter, compared to analysts’ expectations of $893.18 million. Ventas had a net margin of 32.96% and a return on equity of 6.34%. Ventas’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.03 earnings per share. sell-side analysts predict that Ventas will post 4.16 EPS for the current year.
Several large investors have recently modified their holdings of VTR. Amica Retiree Medical Trust acquired a new stake in shares of Ventas during the third quarter worth $131,000. Bronfman E.L. Rothschild L.P. raised its holdings in shares of Ventas by 48.0% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 2,003 shares of the real estate investment trust’s stock worth $139,000 after purchasing an additional 650 shares during the period. Cable Hill Partners LLC acquired a new stake in shares of Ventas during the third quarter worth $174,000. Northern Capital Management LLC acquired a new stake in shares of Ventas during the second quarter worth $202,000. Finally, Honkamp Krueger Financial Services Inc. acquired a new stake in shares of Ventas during the second quarter worth $203,000. 90.39% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Zacks Investment Research Upgrades Ventas (NYSE:VTR) to “Hold”” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/12/08/ventas-inc-vtr-upgraded-by-zacks-investment-research-to-hold.html.
Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.
Get a free copy of the Zacks research report on Ventas (VTR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ventas Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc. and related companies with MarketBeat.com's FREE daily email newsletter.